 |
|
|
Meclonazepam
|
|
| Systematic (IUPAC) name | |
| (3S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | |
| Identifiers | |
| CAS number | |
| ATC code | none |
| PubChem | |
| Chemical data | |
| Formula | C16H12ClN3O3 |
| Mol. mass | 329.74 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Meclonazepam ((S)-3-methylclonazepam) is a drug which is a benzodiazepine derivative similar in structure to clonazepam.[1] It has sedative and anxiolytic actions like those of other benzodiazepines,[1] and also has anti-parasitic effects against the parasitic worm Schistosoma mansoni.[2]
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
See also
References
- ^ Ansseau M, Doumont A, Thiry D, von Frenckell R, Collard J. Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over design. Psychopharmacology (Berlin). 1985;87(2):130-5.
- ^ O'Boyle C, Lambe R, Darragh A. Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam. European Journal of Clinical Pharmacology. 1985;29(1):105-8.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
